Alliancebernstein L.P. Rocket Pharmaceuticals, Inc. Transaction History

Alliancebernstein L.P.

$278 Billion
Q2 2024

A detailed history of Alliancebernstein L.P. transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 261,347 shares of RCKT stock, worth $4.82 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

261,347

Previous 155,244 68.35%

Holding current value

$4.82 Million

Previous $4.18 Million 34.53%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$20.66 - $26.72 $2.19 Million - $2.84 Million	106,103 Added 68.35%	261,347 $5.63 Million
Q1 2024 May 14, 2024	BUY	$26.16 - $30.74 $2.06 Million - $2.42 Million	78,734 Added 102.91%	155,244 $4.18 Million
Q4 2023 Feb 14, 2024	SELL	$16.78 - $31.94 $840,543 - $1.6 Million	-50,092 Reduced 39.57%	76,510 $2.29 Million
Q3 2023 Nov 14, 2023	BUY	$15.07 - $24.05 $40,568 - $64,742	2,692 Added 2.17%	126,602 $2.59 Million
Q2 2023 Aug 15, 2023	SELL	$16.59 - $23.6 $847,931 - $1.21 Million	-51,111 Reduced 29.2%	123,910 $2.46 Million
Q1 2023 May 15, 2023	BUY	$15.79 - $22.6 $1.99 Million - $2.85 Million	126,121 Added 257.92%	175,021 $3 Million
Q3 2022 Nov 15, 2022	SELL	$12.37 - $18.41 $1.43 Million - $2.14 Million	-115,989 Reduced 70.34%	48,900 $780,000
Q2 2022 Aug 15, 2022	BUY	$7.96 - $16.64 $326,272 - $682,056	40,989 Added 33.08%	164,889 $2.27 Million
Q1 2022 May 13, 2022	SELL	$13.16 - $23.68 $262,041 - $471,516	-19,912 Reduced 13.85%	123,900 $1.97 Million
Q4 2021 Feb 14, 2022	SELL	$21.52 - $36.02 $95,979 - $160,649	-4,460 Reduced 3.01%	143,812 $3.14 Million
Q3 2021 Nov 10, 2021	BUY	$27.42 - $48.97 $2.56 Million - $4.58 Million	93,425 Added 170.34%	148,272 $4.43 Million
Q2 2021 Jul 30, 2021	BUY	$39.41 - $47.25 $238,312 - $285,720	6,047 Added 12.39%	54,847 $2.43 Million
Q1 2021 May 06, 2021	BUY	$43.34 - $65.91 $34,672 - $52,728	800 Added 1.67%	48,800 $2.17 Million
Q4 2020 Feb 08, 2021	BUY	$23.3 - $59.57 $302,900 - $774,410	13,000 Added 37.14%	48,000 $2.63 Million
Q3 2020 Nov 12, 2020	SELL	$20.5 - $28.59 $28,700 - $40,026	-1,400 Reduced 3.85%	35,000 $800,000
Q2 2020 Aug 13, 2020	BUY	$13.32 - $22.61 $18,648 - $31,654	1,400 Added 4.0%	36,400 $762,000
Q1 2020 May 14, 2020	SELL	$9.71 - $25.11 $23,304 - $60,264	-2,400 Reduced 6.42%	35,000 $488,000
Q4 2019 Feb 18, 2020	SELL	$11.07 - $24.23 $43,173 - $94,497	-3,900 Reduced 9.44%	37,400 $851,000
Q3 2019 Nov 14, 2019	BUY	$10.85 - $14.78 $113,925 - $155,190	10,500 Added 34.09%	41,300 $481,000
Q2 2019 Aug 14, 2019	BUY	$15.0 - $19.81 $99,000 - $130,745	6,600 Added 27.27%	30,800 $462,000
Q1 2019 May 14, 2019	BUY	$13.45 - $19.01 $53,800 - $76,040	4,000 Added 19.8%	24,200 $424,000
Q4 2018 Feb 13, 2019	BUY	$11.21 - $23.53 $57,171 - $120,003	5,100 Added 33.77%	20,200 $299,000
Q3 2018 Nov 08, 2018	SELL	$18.5 - $25.49 $828,800 - $1.14 Million	-44,800 Reduced 74.79%	15,100 $372,000
Q2 2018 Aug 13, 2018	BUY	$14.58 - $23.0 $873,342 - $1.38 Million	59,900 New	59,900 $1.18 Million

Others Institutions Holding RCKT

# of Institutions

194

Shares Held

91.9M

Call Options Held

222K

Put Options Held

111K

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $1.4B
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Rocket Pharmaceuticals, Inc. Transaction History